Detailed Mechanism Funding and Narrative

Years of mechanism: 2014 2015 2016 2017 2018 2019

Details for Mechanism ID: 17463
Country/Region: Eswatini
Year: 2015
Main Partner: Columbia University
Main Partner Program: International Center for AIDS Care and Treatment Programs
Organizational Type: University
Funding Agency: HHS/CDC
Total Funding: $5,297,575 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $422,663
Care: TB/HIV (HVTB) $175,113
Care: Pediatric Care and Support (PDCS) $256,043
Testing: HIV Testing and Counseling (HVCT) $257,049
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $98,427
Treatment: Adult Treatment (HTXS) $3,798,748
Treatment: Pediatric Treatment (PDTX) $289,532
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
CARE_CURR Age/sex: <1 Female 2016 3
CARE_CURR Age/sex: <1 Female 2016 63
CARE_CURR Age/sex: <1 Male 2016 59
CARE_CURR Age/sex: 1-4 Female 2016 2
CARE_CURR Age/sex: 1-4 Female 2016 294
CARE_CURR Age/sex: 1-4 Male 2016 287
CARE_CURR Age/sex: 10-14 Female 2016 1
CARE_CURR Age/sex: 10-14 Female 2016 402
CARE_CURR Age/sex: 10-14 Male 2016 435
CARE_CURR Age/sex: 15-19 Female 2016 14
CARE_CURR Age/sex: 15-19 Female 2016 1,008
CARE_CURR Age/sex: 15-19 Male 2016 286
CARE_CURR Age/sex: 20-24 Female 2016 80
CARE_CURR Age/sex: 20-24 Female 2016 3,682
CARE_CURR Age/sex: 20-24 Male 2016 14
CARE_CURR Age/sex: 20-24 Male 2016 479
CARE_CURR Age/sex: 25-49 Female 2016 215
CARE_CURR Age/sex: 25-49 Female 2016 19,307
CARE_CURR Age/sex: 25-49 Male 2016 815
CARE_CURR Age/sex: 25-49 Male 2016 10,423
CARE_CURR Age/sex: 5-9 Female 2016 3
CARE_CURR Age/sex: 5-9 Female 2016 413
CARE_CURR Age/sex: 5-9 Male 2016 345
CARE_CURR Age/sex: 50+ Female 2016 29
CARE_CURR Age/sex: 50+ Female 2016 4,045
CARE_CURR Age/sex: 50+ Male 2016 23
CARE_CURR Age/sex: 50+ Male 2016 2,508
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2016 2
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2016 39
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2016 42
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2016 104
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2016 1,199
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2016 75
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2016 536
CARE_CURR Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 1,579
CARE_CURR Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 44,036
CARE_CURR Sum of Age/Sex disaggregates 2016 1,199
CARE_CURR Sum of Age/Sex disaggregates 2016 44,036
CARE_CURR Sum of Aggregated Age/Sex disaggregates 2016 181
CARE_CURR Sum of Aggregated Age/Sex disaggregates 2016 1,816
CARE_NEW Age/sex: <1 Female 2016 32
CARE_NEW Age/sex: <1 Male 2016 32
CARE_NEW Age/sex: 1-4 Female 2016 74
CARE_NEW Age/sex: 1-4 Male 2016 76
CARE_NEW Age/sex: 10-14 Female 2016 50
CARE_NEW Age/sex: 10-14 Male 2016 108
CARE_NEW Age/sex: 15-19 Female 2016 366
CARE_NEW Age/sex: 15-19 Male 2016 29
CARE_NEW Age/sex: 20-24 Female 2016 1,432
CARE_NEW Age/sex: 20-24 Male 2016 212
CARE_NEW Age/sex: 25-49 Female 2016 3,089
CARE_NEW Age/sex: 25-49 Male 2016 2,215
CARE_NEW Age/sex: 5-9 Female 2016 46
CARE_NEW Age/sex: 5-9 Male 2016 57
CARE_NEW Age/sex: 50+ Female 2016 459
CARE_NEW Age/sex: 50+ Male 2016 303
CARE_NEW Number of HIV-infected adults and children newly enrolled in clinical care during the reporting period and received at least one of the following at enrollment: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 8,580
CARE_NEW Sum of Age/sex disaggregates 2016 8,580
FPINT_SITE Number of service delivery points supported by PEPFAR for HIV services that are directly providing integrated voluntary family planning services 2016 117
FPINT_SITE Total number of PEPFAR-supported HIV service delivery points: PMTCT, Care and Treatment 2016 117
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2016 66
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2016 69
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2016 833
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2016 878
HTS_TST By Test Result: Negative 2016 1,596
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2016 1,846
HTS_TST Sum of Aggregated Age/Sex <15 2016 135
HTS_TST Sum of Aggregated Age/Sex 15+ 2016 1,711
HTS_TST Sum of Aggregated Age/Sex disaggregates 2016 1,846
HTS_TST Sum of Test Result disaggregates 2016 1,846
HTS_TST_POS By Test Result: Positive 2016 250
PMTCT_ARV Number of HIV- positive pregnant women identified in the reporting period (including known HIV-positive at entry) 2016 67
PMTCT_ARV Number of HIV-positive pregnant women who received antiretrovirals to reduce risk of mother-to-child-transmission (MTCT) during pregnancy and delivery 2016 56
PMTCT_ARV Sub-Disag of Life-long ART: Already on treatment at the beginning of the current pregnancy 2016 22
PMTCT_ARV Sub-Disag of Life-long ART: Newly initiated on treatment during the current pregnancy 2016 34
PMTCT_ARV Sum of New and Current disaggregates 2016 56
PMTCT_EID By infants who received a virologic test within 2 months of birth 2016 3,127
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2016 303
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2016 3,430
PMTCT_EID Sum of Infant Age disaggregates 2016 3,430
PMTCT_STAT By: Known positives at entry 2016 160
PMTCT_STAT By: Number of new positives identified 2016 31
PMTCT_STAT Number of new ANC and L&D clients 2016 200
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2016 191
PMTCT_STAT Sum of Positives Status disaggregates 2016 191
TB_SCREEN Age: <1 2016 63
TB_SCREEN Age: 1-4 2016 541
TB_SCREEN Age: 10-14 2016 986
TB_SCREEN Age: 15-19 2016 866
TB_SCREEN Age: 5-9 2016 906
TB_SCREEN Aggregated Age - USE WITH HQ PERMISSION ONLY: <15 2016 242
TB_SCREEN Aggregated Age - USE WITH HQ PERMISSION ONLY: 15+ 2016 3,564
TB_SCREEN Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 1,579
TB_SCREEN Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 44,036
TB_SCREEN Sex: Female 2016 24,679
TB_SCREEN Sex: Male 2016 14,501
TB_SCREEN Sum of Age disaggregates 2016 39,180
TB_SCREEN Sum of Aggregated Age disaggregates 2016 3,806
TB_SCREEN Sum of Sex disaggregates 2016 39,180
TB_SCREEN The number of PLHIV who were screened for TB symptoms at the last clinical visit to an HIV care facility during the reporting period 2016 39,180
TX_CURR Age/Sex: <1 Female 2016 4
TX_CURR Age/Sex: <1 Female 2016 35
TX_CURR Age/Sex: <1 Male 2016 32
TX_CURR Age/Sex: 1-4 Female 2016 2
TX_CURR Age/Sex: 1-4 Female 2016 390
TX_CURR Age/Sex: 1-4 Male 2016 293
TX_CURR Age/Sex: 5-14 Female 2016 8
TX_CURR Age/Sex: 5-14 Female 2016 978
TX_CURR Age/Sex: 5-14 Male 2016 888
TX_CURR Aggregated Age/Sex: <1 Male 2016 1
TX_CURR Aggregated Age/Sex: 15+ Female 2016 151
TX_CURR Aggregated Age/Sex: 15+ Male 2016 188
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2016 307
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2016 41,208
TX_CURR Sum of age/sex disaggregates 2016 41,208
TX_CURR Sum of Age/Sex disaggregations 2016 307
TX_CURR Sum of Aggregated Age/Sex (<1 and 1-14) <15 2016 16
TX_CURR Sum of Aggregated Age/Sex 15+ 2016 339
TX_CURR Sum of Aggregated Age/Sex disaggregates 2016 339
TX_NEW By Age/Sex: <1 Female 2016 33
TX_NEW By Age/Sex: <1 Male 2016 34
TX_NEW By Age/Sex: 1-4 Female 2016 81
TX_NEW By Age/Sex: 1-4 Male 2016 83
TX_NEW By Age/Sex: 10-14 Female 2016 52
TX_NEW By Age/Sex: 10-14 Male 2016 120
TX_NEW By Age/Sex: 15-19 Female 2016 327
TX_NEW By Age/Sex: 15-19 Male 2016 33
TX_NEW By Age/Sex: 20-24 Female 2016 1,294
TX_NEW By Age/Sex: 20-24 Male 2016 213
TX_NEW By Age/Sex: 25-49 Female 2016 2,803
TX_NEW By Age/Sex: 25-49 Male 2016 2,056
TX_NEW By Age/Sex: 5-9 Female 2016 47
TX_NEW By Age/Sex: 5-9 Male 2016 61
TX_NEW By Age/Sex: 50+ Female 2016 413
TX_NEW By Age/Sex: 50+ Male 2016 269
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2016 7,919
TX_NEW Sum of Age/Sex disaggregates 2016 7,919
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2016 3,653
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2016 4,001
Cross Cutting Budget Categories and Known Amounts Total: $715,000
Human Resources for Health $150,000
Food and Nutrition: Policy, Tools, and Service Delivery $200,000
Gender: Gender Based Violence (GBV) $75,000
GBV Prevention
Collection and Use of Gender-related Strategic Information
Gender: Gender Equality $100,000
Increase gender-equitable access to income and productive resources, including education
Implementation
Capacity building
Equity in HIV prevention, care, treatment and support
Collection and Use of Gender-related Strategic Information
Capacity building
Motor Vehicles: Purchased $190,000